Biotech

All Articles

' Medical instinct' led FDA specialists to back Zevra's uncommon illness med

.Zevra Rehabs' unusual illness medication seems to become on the pathway to confirmation this loss a...

Pfizer takes $230M attacked after axing neglected DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failure has actually gone a $23...

AC Immune finds 'spots' potential in Alzheimer's medicine records

.After much more than two decades of deal with neurodegenerative diseases, Swiss biotech AC Invulner...

GSK loses ph. 2 HPV injection over absence of best-in-class potential

.GSK has broken up a period 2 human papillomavirus (HPV) vaccine from its pipeline after deciding th...

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.OS Therapies are going to specify on the NYSE American inventory exchange this morning using a $6.4...

ALX's fizzling CD47 response price sends out sell spiraling down

.ALX Oncology's stage 2 stomach cancer cells reaction rate has actually damaged. After seeing its ow...

Ionis centers eye ailment from targets of Roche-partnered prospect after information dissatisfy

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has disappointed desires, cuing t...

Biogen's chief executive officer claimed no dangerous deals in 2023. He prepares to be vibrant

.While Biogen's pharma peers are searching for late-stage assets with little bit of risk, CEO Chris ...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Bio has been actually a biotech in search of a pipe after it scrapped its own lead possessio...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back rights to an early Alzheimer's ailment plan to Denali Rehabs, leaving a larg...